 |
US panel rejects Arena diet drugArena Pharmaceuticals suffered a major setback on Thursday when US advisers rejected its proposed weight-loss pill amid concerns that tumors in rats might indicate a risk of cancer in humans. Lorcaserin, Arena's most advanced drug cand More… |
Thursday 14 November 2024
